14-day Premium Trial Subscription Try For FreeTry Free

CPRX Upcoming Earnings (Q1 2024)

Earnings Date: May 08, 2024
Consensus EPS: Premium

Current P/E* ratio: 25.01 | Price (Feb 28, 2024, EOD): $14.56

*The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.

Earnings Per Share

Last 3 Quarters for CPRX Premium

Below you can see how CPRX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Earnings Report Demo

FAQ

FAQ

When is the earnings report for CPRX?
Catalyst Pharmaceuticals (CPRX) has scheduled its earnings report for Feb 28, 2024 after the markets close.

What is the CPRX price-to-earnings (P/E) ratio?
CPRX P/E ratio as of Feb 28, 2024 (TTM) is 24.36.

What is the CPRX EPS forecast?
The forecasted EPS (Earnings Per Share) for Catalyst Pharmaceuticals (CPRX) for the first fiscal quarter 2023 is $0.480.

What are Catalyst Pharmaceuticals's retained earnings?
On its balance sheet, Catalyst Pharmaceuticals reported retained earnings of $0 for the latest quarter ending Dec 30, 2023.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.

Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT